Different pressor and bronchoconstrictor properties of human big‐endothelin‐1, 2 (1–38) and 3 in ketamine/xylazine‐anaesthetized guinea‐pigs
- 1 February 1995
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 114 (3) , 720-726
- https://doi.org/10.1111/j.1476-5381.1995.tb17198.x
Abstract
1. In the present study, the precursors of endothelin-1, endothelin-2 and endothelin-3 were tested for their pressor and bronchoconstrictor properties in the anaesthetized guinea-pig. In addition, the effects of big-endothelin-1 and endothelin-1 were assessed under urethane or ketamine/xylazine anaesthesia. 2. When compared to ketamine/xylazine, urethane markedly depressed the pressor and bronchoconstrictor properties of endothelin-1 and big-endothelin-1. 3. Under ketamine/xylazine anaesthesia, the three endothelins induced a biphasic increase of mean arterial blood pressure. In contrast, big-endothelin-1, as well as big-endothelin-2 (1-38), induced only sustained increase in blood pressure whereas big-endothelin-3 was inactive at doses up to 25 nmol kg-1. 4. Big-endothelin-1, but not big-endothelin-2, induced a significant increase in airway resistance. Yet, endothelin-1, endothelin-2 and endothelin-3 were equipotent as bronchoconstrictor agents. 5. Big-endothelin-1, endothelin-1 and endothelin-2, but not big-endothelin-2, triggered a marked release of prostacyclin and thromboxane A2 from the guinea-pig perfused lung. 6. Our results suggest the presence of a phosphoramidon-sensitive endothelin-converting enzyme (ECE) which is responsible for the conversion of big-endothelin-1 and big-endothelin-2 to their active moieties, endothelin-1 and 2. However, the lack of bronchoconstrictor and eicosanoid-releasing properties of big-endothelin-2, as opposed to endothelin-2 or big-endothelin-1, suggests the presence of two distinct phosphoramidon-sensitive ECEs in the guinea-pig. The ECE responsible for the systemic conversion of big-endothelins possesses the same affinity for big-endothelin-l and 2 but not big-endothelin-3. In contrast, in the pulmonary vasculature is localized in the vicinity of the sites responsible for eicosanoid release, an ECE which converts more readily big-endothelin-1 than big-endothelin-2.Keywords
This publication has 26 references indexed in Scilit:
- Characterization of phosphoramidon-sensitive metalloproteinases with endothelin-converting enzyme activity in porcine lung membraneBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1993
- Big endothelin-3-induced hypertension and its inhibition by phosphoramidon in anaesthetized ratsEuropean Journal of Pharmacology, 1993
- Effect of phosphoramidon on big endothelin‐2 conversion into endothelin‐2 in human renal adenocarcinoma (ACHN) cells Analysis of endothelin‐2 biosynthetic pathwayFEBS Letters, 1992
- Anatomical localization and pharmacological activity of mature endothelins and their precursors in human vascular tissueJournal Of Hypertension, 1992
- Human Big Endothelin Releases Prostacyclin in vivo and in vitro Through a Phosphoramidon-Sensitive Conversion to Endothelin-1Journal of Cardiovascular Pharmacology, 1991
- Bronchopulmonary and Pressor Activities of Endothelin-1 (ET-1), ET-2, ET-3, and Big ET-1 in the Guinea PigJournal of Cardiovascular Pharmacology, 1991
- Inhibition of biological actions of big endothelin-1 by phosphoramidonBiochemical and Biophysical Research Communications, 1990
- Putative precursors of endothelin have less vasoconstrictor activity in vitro but a potent pressor effect in vivoFEBS Letters, 1989
- Versuchsanordnung zu Untersuchungen an der BronchiàlmuskulaturNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1940